Medication info
Raniton Tablets 150 mg (Ranitidine Hydrochloride)

Raniton Tablets 150 mg (Ranitidine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
Off-white to pale yellow round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201601179 · Approved 2016.02.29

Summary

Main use
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The dosage regimen is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, and diseases caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg of this medicine 3 times daily and increase the dose as necessary. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration of 150 mg of this medicine twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, swelling) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or lower, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
For ages 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers due to NSAID use
  • gastric mucosal lesions (erosions
  • bleeding
  • redness
  • swelling)
  • acute gastritis
  • acute exacerbation of chronic gastritis
View approved original text

This medication is used to treat gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome during preoperative anesthesia, and is effective for ulcers occurring after surgery and for those caused by non-steroidal anti-inflammatory drugs (NSAIDs). It helps improve gastric mucosal lesions such as erosions, bleeding, redness, and swelling associated with exacerbations of acute and chronic gastritis, as well as upper gastrointestinal bleeding. This medication contributes to digestive health by protecting the gastric mucosa and improving damaged areas.

How to take

Adult dose

Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The dosage regimen is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, and diseases caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg of this medicine 3 times daily and increase the dose as necessary. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration of 150 mg of this medicine twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, swelling) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or lower, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

For ages 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Precautions

This medication should not be used in patients with known hypersensitivity to any component of this medication or with a history of acute porphyria. Since this medication contains lactose, it should not be administered to patients with lactose intolerance or specific genetic metabolic disorders. Patients with impaired kidney function may have elevated blood levels of this medication, so doses should be reduced or dosing intervals increased with caution. Patients with liver dysfunction should also be treated with caution, and individuals with a history of drug hypersensitivity or elderly individuals should be careful. When used in conjunction with non-steroidal anti-inflammatory drugs, particularly for elderly patients or those with a history of peptic ulcers, regular monitoring of their condition is advised. This medication may mask the symptoms of gastric cancer, so patients with gastric ulcers or newly appearing dyspepsia symptoms in middle-aged or older adults should confirm the malignancy before use. Patients with non-Helycobacter pylori-positive gastric and duodenal ulcers require concomitant eradication therapy. Rarely, anaphylactic shock, urticaria, angioedema, rashes, and difficulty breathing may occur as hypersensitive reactions during medication, so if unusual symptoms arise, discontinue use immediately and consult a medical professional. Abnormal laboratory findings such as liver function abnormalities, arrhythmias, gastrointestinal symptoms, and neurological and psychiatric symptoms may occur, so close observation is required. If dizziness or drowsiness occurs, it is safer to avoid driving or operating dangerous machinery. This medication may interact with other drugs, so inform your healthcare provider about any concurrent medications, especially when taking anticoagulants, as blood coagulation status should be frequently monitored. Women who are pregnant or potentially pregnant, as well as nursing mothers, should carefully consider the use of this medication and consult a physician if necessary. Safety for children has not been sufficiently confirmed, so caution is needed when using. Elderly individuals may have elevated drug levels due to decreased kidney function, so dosing and dosing intervals should be adjusted accordingly. Signs of overdose are rare, but appropriate treatment such as vomiting or gastric lavage may be needed, and in severe cases, blood dialysis may be considered. This medication should be kept out of the reach of children, and transferring it to another container should be avoided to maintain quality and safety. Long-term use may necessitate ophthalmic examinations due to affinity to ocular melanin, and caution should be taken against bacterial overgrowth due to gastric acid secretion inhibition.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 58 more
  • leukopenia
  • thrombocytopenia
  • bone marrow suppression
  • aplastic anemia
  • aplastic bone marrow
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • systemic lethargy
  • weakness
  • subcutaneous and mucosal bleeding
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizure
  • headache
  • heaviness of the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movements
  • altered consciousness
  • liver hypertrophy muscle spasms
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a light-blocking container. Additionally, it is important to maintain a room temperature between 1 degree and 30 degrees Celsius when storing this medication. This way, the medication's efficacy can be well preserved and prevent degradation.

Appearance and packaging

Appearance

Off-white to pale yellow round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.